Prince Henry's Institute, Clayton 3168, Victoria, Australia.
Endocrinology. 2012 Jul;153(7):3416-25. doi: 10.1210/en.2011-2098. Epub 2012 May 31.
Mineralocorticoid receptor (MR) activation promotes the development of cardiac fibrosis and heart failure. Clinical evidence demonstrates that MR antagonism is protective even when plasma aldosterone levels are not increased. We hypothesize that MR activation in macrophages drives the profibrotic phenotype in the heart even when aldosterone levels are not elevated. The aim of the present study was to establish the role of macrophage MR signaling in mediating cardiac tissue remodeling caused by nitric oxide (NO) deficiency, a mineralocorticoid-independent insult. Male wild-type (MRflox/flox) and macrophage MR-knockout (MRflox/flox/LysMCre/+; mac-MRKO) mice were uninephrectomized, maintained on 0.9% NaCl drinking solution, with either vehicle (control) or the nitric oxide synthase (NOS) inhibitor NG-nitro-l-arginine methyl ester (L-NAME; 150 mg/kg/d) for 8 wk. NO deficiency increased systolic blood pressure at 4 wk in wild-type L-NAME/salt-treated mice compared with all other groups. At 8 wk, systolic blood pressure was increased above control in both L-NAME/salt treated wild-type and mac-MRKO mice by approximately 28 mm Hg by L-NAME/salt. Recruitment of macrophages was increased 2- to 3-fold in both L-NAME/salt treated wild-type and mac-MRKO. Inducible NOS positive macrophage infiltration and TNFα mRNA expression was greater in wild-type L-NAME/salt-treated mice compared with mac-MRKO, demonstrating that loss of MR reduces M1 phenotype. mRNA levels for markers of vascular inflammation and oxidative stress (NADPH oxidase 2, p22phox, intercellular adhesion molecule-1, G protein-coupled chemokine receptor 5) were similar in treated wild-type and mac-MRKO mice compared with control groups. In contrast, L-NAME/salt treatment increased interstitial collagen deposition in wild-type by about 33% but not in mac-MRKO mice. mRNA levels for connective tissue growth factor and collagen III were also increased above control treatment in wild-type (1.931 ± 0.215 vs. 1 ± 0.073) but not mac-MRKO mice (1.403 ± 0.150 vs. 1.286 ± 0.255). These data demonstrate that macrophage MR are necessary for the translation of inflammation and oxidative stress into interstitial and perivascular fibrosis after NO deficiency, even when plasma aldosterone is not elevated.
醛固酮受体(MR)激活可促进心肌纤维化和心力衰竭的发展。临床证据表明,即使血浆醛固酮水平没有升高,MR 拮抗作用也是有保护作用的。我们假设,即使醛固酮水平不升高,MR 在巨噬细胞中的激活也会驱动心脏中的促纤维化表型。本研究旨在确定巨噬细胞 MR 信号在介导一氧化氮(NO)缺乏引起的心肌组织重构中的作用,NO 缺乏是一种非醛固酮依赖性损伤。雄性野生型(MRflox/flox)和巨噬细胞 MR 敲除(MRflox/flox/LysMCre/+;mac-MRKO)小鼠行单侧肾切除术,给予 0.9%NaCl 饮用水,给予载体(对照)或一氧化氮合酶(NOS)抑制剂 NG-硝基-L-精氨酸甲酯(L-NAME;150mg/kg/d)8 周。与其他所有组相比,NO 缺乏使野生型 L-NAME/盐处理小鼠在 4 周时收缩压升高。8 周时,L-NAME/盐处理的野生型和 mac-MRKO 小鼠的收缩压均比对照升高约 28mmHg。NO 缺乏使两种 L-NAME/盐处理的野生型和 mac-MRKO 小鼠的巨噬细胞浸润增加 2-3 倍。与 mac-MRKO 相比,野生型 L-NAME/盐处理小鼠的诱导型 NOS 阳性巨噬细胞浸润和 TNFαmRNA 表达增加,表明 MR 缺失减少了 M1 表型。与对照组相比,血管炎症和氧化应激标志物(NADPH 氧化酶 2、p22phox、细胞间黏附分子 1、G 蛋白偶联趋化因子受体 5)的 mRNA 水平在治疗的野生型和 mac-MRKO 小鼠中相似。相比之下,L-NAME/盐处理使野生型小鼠的间质胶原沉积增加约 33%,但 mac-MRKO 小鼠没有增加。与对照处理相比,结缔组织生长因子和胶原 III 的 mRNA 水平在野生型小鼠中也升高(1.931±0.215 比 1.00±0.073),但在 mac-MRKO 小鼠中没有升高(1.403±0.150 比 1.286±0.255)。这些数据表明,即使在血浆醛固酮没有升高的情况下,MR 也可使巨噬细胞介导的炎症和氧化应激转化为 NO 缺乏后的间质和血管周围纤维化。